BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

36 related articles for article (PubMed ID: 29983167)

  • 1. Preparation of high-efficiency HILIC capillary columns utilizing slurry packing at 2100 bar.
    Anderson BG; Hancock TA; Kennedy RT
    J Chromatogr A; 2024 May; 1722():464856. PubMed ID: 38579610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Separation and identification of oligonucleotides by hydrophilic interaction liquid chromatography (HILIC)-inductively coupled plasma mass spectrometry (ICPMS).
    Easter RN; Kröning KK; Caruso JA; Limbach PA
    Analyst; 2010 Oct; 135(10):2560-5. PubMed ID: 20830328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-nucleotide resolution of RNAs up to 59 nucleotides by high-performance liquid chromatography.
    Huang Z; Jayaseelan S; Hebert J; Seo H; Niu L
    Anal Biochem; 2013 Apr; 435(1):35-43. PubMed ID: 23274387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability indicating ion-pair reversed-phase liquid chromatography method for modified mRNA.
    Currie J; Dahlberg JR; Lundberg E; Thunberg L; Eriksson J; Schweikart F; Nilsson GA; Örnskov E
    J Pharm Biomed Anal; 2024 Aug; 245():116144. PubMed ID: 38636193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Running the assay of 2023 and introducing
    Lodge J
    Bioanalysis; 2024 Jan; 16(1):1-4. PubMed ID: 37937946
    [No Abstract]   [Full Text] [Related]  

  • 6. [Stationary phases for hydrophilic interaction liquid chromatography and their applications in separation of traditional Chinese medicines].
    Guo Z; Zhang X; Xu Q; Liang X
    Se Pu; 2009 Sep; 27(5):675-81. PubMed ID: 20073204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, characterization, and application of a novel multifunctional stationary phase for hydrophilic interaction/reversed phase mixed-mode chromatography.
    Aral H; Çelik KS; Altındağ R; Aral T
    Talanta; 2017 Nov; 174():703-714. PubMed ID: 28738646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydrophilic interaction chromatography coupled to tandem mass spectrometry in the presence of hydrophilic ion-pairing reagents for the separation of nucleosides and nucleotide mono-, di- and triphosphates.
    Mateos-Vivas M; Rodríguez-Gonzalo E; García-Gómez D; Carabias-Martínez R
    J Chromatogr A; 2015 Oct; 1414():129-37. PubMed ID: 26341591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Method optimization of hydrophilic interaction chromatography separation of nucleotides using design of experiment approaches I: Comparison of several zwitterionic columns.
    Arase S; Kimura S; Ikegami T
    J Pharm Biomed Anal; 2018 Sep; 158():307-316. PubMed ID: 29909320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of coverage, retention patterns, and selectivity of seven liquid chromatographic methods for metabolomics.
    Wernisch S; Pennathur S
    Anal Bioanal Chem; 2016 Sep; 408(22):6079-91. PubMed ID: 27370688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Dilute-and-inject" multi-target screening assay for highly polar doping agents using hydrophilic interaction liquid chromatography high resolution/high accuracy mass spectrometry for sports drug testing.
    Görgens C; Guddat S; Orlovius AK; Sigmund G; Thomas A; Thevis M; Schänzer W
    Anal Bioanal Chem; 2015 Jul; 407(18):5365-79. PubMed ID: 25925859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Separation of highly charged compounds using competing ions with hydrophilic interaction liquid chromatography - Application to assay of cellular nucleotides.
    Hewavitharana AK; Narayan V; Duley JA
    J Chromatogr A; 2018 Sep; 1567():233-238. PubMed ID: 29983167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mobile phase effects on the retention on polar columns with special attention to the dual hydrophilic interaction-reversed-phase liquid chromatography mechanism, a review.
    Jandera P; Hájek T
    J Sep Sci; 2018 Jan; 41(1):145-162. PubMed ID: 29072360
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.